Related Experiment Video
Updated: May 20, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Ubiquitin removal in the TGF-β pathway
Kamna Aggarwal1, Joan Massagué
1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. massaguj@mskcc.org
Nature Cell Biology
|June 30, 2012
Summary
Two deubiquitinating enzymes, USP4 and USP15, regulate the transforming growth factor-beta (TGF-β) pathway by stabilizing its type I receptor. These enzymes protect the receptor from degradation, influencing cell signaling.
Area of Science:
- Cell biology
- Molecular biology
- Biochemistry
Background:
- The transforming growth factor-beta (TGF-β) pathway plays crucial roles in cellular processes.
- Ubiquitin-mediated proteolysis is a key regulatory mechanism for the TGF-β pathway.
- Deubiquitinating enzymes (DUBs) are emerging as important regulators in various signaling pathways.
Purpose of the Study:
- To identify deubiquitinating enzymes that regulate the TGF-β type I receptor.
- To elucidate the mechanisms by which DUBs affect TGF-β receptor stability and signaling.
Main Methods:
- Proteasomal degradation assays
- Immunoprecipitation
- Western blotting
- Analysis of deubiquitinating enzyme activity on TGF-β type I receptor.
Main Results:
- Two DUBs, ubiquitin-specific peptidase-4 (USP4) and ubiquitin-specific peptidase-15 (USP15), were identified as deubiquitinating enzymes for the TGF-β type I receptor.
- Both USP4 and USP15 were found to stabilize the activated TGF-β type I receptor.
- USP4 and USP15 act through distinct mechanisms to counteract receptor ubiquitination and degradation.
Conclusions:
- USP4 and USP15 are critical regulators of TGF-β signaling by controlling the stability of its type I receptor.
- These findings reveal novel insights into the intricate regulation of the TGF-β pathway.
- Targeting USP4 and USP15 may offer therapeutic strategies for diseases involving TGF-β signaling dysregulation.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
02:58Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
01:37The Unfolded Protein Response
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...